Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia [Phase 4]
A Phase 4 trial comparing olanzapine to an active comparator in depression associated with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder [Phase 4]
Phase 4 trial completed evaluating a weight-gain agent for treating olanzapine-associated weight gain in patients with schizophrenia, schizo…
-
CLINICAL_TRIALS trial_result · 2006-05-31Clinical Trial Update: Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism [Phase 4]
Phase 4 clinical trial evaluating risperidone and olanzapine for schizophrenia patients with neuroleptic-induced acute dystonia or Parkinson…
-
CLINICAL_TRIALS trial_result · 2006-05-22Clinical Trial Update: Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression [Phase 3]
A Phase 3 trial evaluating an anti-Toxoplasma gondii add-on therapy in Toxoplasma seropositive individuals with schizophrenia or major depre…
-
CLINICAL_TRIALS trial_result · 2006-05-19Clinical Trial Update: Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia [Phase 2]
A Phase 2 trial evaluating sarcosine as a monotherapy for schizophrenia has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-05-08Clinical Trial Update: CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia [Phase 4]
CARE, a Phase 4 trial sponsored by the University of British Columbia, evaluating treatment for the most severely ill patients with schizoph…
-
CLINICAL_TRIALS trial_result · 2006-05-03Clinical Trial Update: D-Serine Monotherapy for Schizophrenia [Phase 1, Phase 2]
D-Serine monotherapy is being studied for schizophrenia in Phase 1 and Phase 2 trials; the current status of the trial is unknown.